EP2430164A4 - Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein - Google Patents
Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids thereinInfo
- Publication number
- EP2430164A4 EP2430164A4 EP10775323A EP10775323A EP2430164A4 EP 2430164 A4 EP2430164 A4 EP 2430164A4 EP 10775323 A EP10775323 A EP 10775323A EP 10775323 A EP10775323 A EP 10775323A EP 2430164 A4 EP2430164 A4 EP 2430164A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- incorporation
- production
- amino acids
- natural amino
- recombinant proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
- 238000010348 incorporation Methods 0.000 title 1
- 230000001937 non-anti-biotic effect Effects 0.000 title 1
- 238000010187 selection method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17726709P | 2009-05-11 | 2009-05-11 | |
PCT/US2010/034201 WO2010132341A2 (en) | 2009-05-11 | 2010-05-10 | Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2430164A2 EP2430164A2 (en) | 2012-03-21 |
EP2430164A4 true EP2430164A4 (en) | 2012-10-31 |
EP2430164B1 EP2430164B1 (en) | 2017-07-19 |
Family
ID=43085513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10775323.8A Active EP2430164B1 (en) | 2009-05-11 | 2010-05-10 | Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein |
Country Status (7)
Country | Link |
---|---|
US (2) | US9243253B2 (en) |
EP (1) | EP2430164B1 (en) |
AU (2) | AU2010247938B2 (en) |
CA (1) | CA2761578C (en) |
ES (1) | ES2640947T3 (en) |
NZ (1) | NZ596283A (en) |
WO (1) | WO2010132341A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2723872A1 (en) * | 2011-06-24 | 2014-04-30 | Algenol Biofuels Inc. | Genetically enhanced cyanobacteria lacking functional genes conferring biocide resistance for the production of chemical compounds |
WO2014100798A1 (en) * | 2012-12-21 | 2014-06-26 | Algenol Biofuels, Inc. | Novel shuttle vector capable of transforming multiple genera of cyanobacteria |
KR101660580B1 (en) * | 2014-04-02 | 2016-09-28 | 프레스티지 바이오파마 피티이. 엘티디. | A method for preparing an antibody by controlling a sugar content of the antibody |
MX2016014824A (en) | 2014-05-13 | 2017-03-23 | Bioatla Llc | Conditionally active biological proteins. |
WO2016004024A1 (en) * | 2014-07-02 | 2016-01-07 | Sutro Biopharma, Inc. | High growth capacity auxotrophic escherichia coli and methods of use |
EP3189152A4 (en) | 2014-09-03 | 2018-04-04 | BioAtla LLC | Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts |
ES2769877T3 (en) * | 2014-10-23 | 2020-06-29 | Sanofi Sa | Novel selection marker for cell transfection and protein production |
EP3353313A2 (en) | 2015-09-23 | 2018-08-01 | Pfizer Inc | Cells and method of cell culture |
BR112018070139A2 (en) * | 2016-03-29 | 2019-02-05 | Geltor Inc | protein expression in gram-negative bacteria where the ratio of periplasmic volume to cytoplasmic volume is between 0.5: 1 and 10: 1 |
US20200056190A1 (en) * | 2017-03-16 | 2020-02-20 | Pfizer Inc. | Tyrosine prototrophy |
KR102166288B1 (en) * | 2019-03-06 | 2020-10-15 | 한국생명공학연구원 | D-glutamate auxotrophic Escherichia coli and method of producing target product |
CN110029068B (en) * | 2019-04-10 | 2022-03-25 | 天津科技大学 | Aspergillus niger genetic engineering strain for high yield of organic acid under low dissolved oxygen condition and application thereof |
WO2020243642A2 (en) * | 2019-05-31 | 2020-12-03 | The Trustees Of Columbia University In The City Of New York | Multiply auxotrophic cell line for the production of recombinant proteins and methods thereof |
CN115322924B (en) * | 2022-07-19 | 2023-11-14 | 济南大学 | Method for synthesizing polyhydroxyalkanoate by double-bacteria mixed culture |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005052151A1 (en) * | 2003-11-19 | 2005-06-09 | Dow Global Technologies Inc. | Improved protein expression systems |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4511503A (en) | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4755465A (en) | 1983-04-25 | 1988-07-05 | Genentech, Inc. | Secretion of correctly processed human growth hormone in E. coli and Pseudomonas |
US4680264A (en) | 1983-07-01 | 1987-07-14 | Lubrizol Genetics, Inc. | Class II mobilizable gram-negative plasmid |
US5281532A (en) | 1983-07-27 | 1994-01-25 | Mycogen Corporation | Pseudomas hosts transformed with bacillus endotoxin genes |
DK594084A (en) | 1984-12-12 | 1986-06-13 | Novo Industri As | PROCEDURE FOR STABILIZING EXTRA-CHROMOSOMAL ELEMENTS IN BACTERIA IN CULTURE |
US4695455A (en) | 1985-01-22 | 1987-09-22 | Mycogen Corporation | Cellular encapsulation of pesticides produced by expression of heterologous genes |
US4695462A (en) | 1985-06-28 | 1987-09-22 | Mycogen Corporation | Cellular encapsulation of biological pesticides |
GB8517071D0 (en) | 1985-07-05 | 1985-08-14 | Hoffmann La Roche | Gram-positive expression control sequence |
US5128130A (en) | 1988-01-22 | 1992-07-07 | Mycogen Corporation | Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens |
US5055294A (en) | 1988-03-03 | 1991-10-08 | Mycogen Corporation | Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens |
US5169760A (en) | 1989-07-27 | 1992-12-08 | Mycogen Corporation | Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters |
US6566121B1 (en) | 1991-06-13 | 2003-05-20 | Albert Einstein College Of Medicine Of Yeshiva University | Insertional mutations in mycobacteria |
US5691185A (en) | 1993-10-08 | 1997-11-25 | Chr. Hansen A/S | Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria |
US5527883A (en) | 1994-05-06 | 1996-06-18 | Mycogen Corporation | Delta-endotoxin expression in pseudomonas fluorescens |
US6291245B1 (en) | 1998-07-15 | 2001-09-18 | Roche Diagnostics Gmbh | Host-vector system |
US6413768B1 (en) | 1998-12-02 | 2002-07-02 | University Of Maryland | Expression plasmids |
DK2322631T3 (en) | 2001-04-19 | 2015-01-12 | Scripps Research Inst | Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA syntetasepar |
CN1678624B (en) | 2002-07-03 | 2011-10-26 | 陶氏环球技术公司 | Benzoate- and anthranilate-inducible promoters |
JP2008525032A (en) | 2004-12-22 | 2008-07-17 | アンブレツクス・インコーポレイテツド | Methods for expressing and purifying recombinant human growth hormone |
JP2009519942A (en) | 2005-12-14 | 2009-05-21 | アンブルックス,インコーポレイテッド | Compositions comprising unnatural amino acids and polypeptides, methods relating thereto, and uses thereof |
CN101528914B (en) | 2006-09-08 | 2014-12-03 | Ambrx公司 | Site specific incorporation of non-natural amino acids by vertebrate cells |
-
2010
- 2010-05-10 WO PCT/US2010/034201 patent/WO2010132341A2/en active Application Filing
- 2010-05-10 EP EP10775323.8A patent/EP2430164B1/en active Active
- 2010-05-10 NZ NZ596283A patent/NZ596283A/en unknown
- 2010-05-10 ES ES10775323.8T patent/ES2640947T3/en active Active
- 2010-05-10 CA CA2761578A patent/CA2761578C/en active Active
- 2010-05-10 AU AU2010247938A patent/AU2010247938B2/en active Active
- 2010-05-10 US US13/319,844 patent/US9243253B2/en active Active
-
2015
- 2015-12-18 US US14/974,897 patent/US9708616B2/en active Active
-
2016
- 2016-05-17 AU AU2016203224A patent/AU2016203224B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005052151A1 (en) * | 2003-11-19 | 2005-06-09 | Dow Global Technologies Inc. | Improved protein expression systems |
Non-Patent Citations (6)
Title |
---|
ALBERT J. DE GRAAF ET AL: "Nonnatural Amino Acids for Site-Specific Protein Conjugation", BIOCONJUGATE CHEMISTRY, vol. 20, no. 7, 3 February 2009 (2009-02-03), pages 1281 - 1295, XP055025160, ISSN: 1043-1802, DOI: 10.1021/bc800294a * |
HENDRICKSON TAMARA L ET AL: "Incorporation of nonnatural amino acids into proteins", ANNUAL REVIEW OF BIOCHEMISTRY, PALTO ALTO, CA, US, vol. 73, 26 March 2004 (2004-03-26), pages 147 - 176, XP009093569, ISSN: 0066-4154, DOI: 10.1146/ANNUREV.BIOCHEM.73.012803.092429 * |
HODGSON D R W ET AL: "THE SYNTHESIS OF PEPTIDES AND PROTEINS CONTAINING NON-NATURAL AMINO ACIDS", CHEMICAL SOCIETY REVIEWS, CHEMICAL SOCIETY, LONDON, GB, vol. 33, no. 7, 1 January 2004 (2004-01-01), pages 422 - 430, XP008067398, ISSN: 0306-0012 * |
K. L. KIICK: "Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation (Supporting information)", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 99, no. 1, 18 December 2001 (2001-12-18), pages 1 - 3, XP055036642, ISSN: 0027-8424, DOI: 10.1073/pnas.012583299 * |
KIICK K L ET AL: "Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 99, no. 1, 8 January 2002 (2002-01-08), pages 19 - 24, XP002904363, ISSN: 0027-8424, DOI: 10.1073/PNAS.012583299 * |
See also references of WO2010132341A2 * |
Also Published As
Publication number | Publication date |
---|---|
US20160208268A1 (en) | 2016-07-21 |
AU2016203224B2 (en) | 2018-02-15 |
EP2430164A2 (en) | 2012-03-21 |
US9708616B2 (en) | 2017-07-18 |
CA2761578A1 (en) | 2010-11-18 |
CA2761578C (en) | 2019-06-18 |
US9243253B2 (en) | 2016-01-26 |
EP2430164B1 (en) | 2017-07-19 |
NZ596283A (en) | 2013-08-30 |
ES2640947T3 (en) | 2017-11-07 |
WO2010132341A3 (en) | 2011-04-21 |
AU2010247938B2 (en) | 2016-02-18 |
WO2010132341A2 (en) | 2010-11-18 |
AU2010247938A1 (en) | 2011-11-24 |
AU2016203224A1 (en) | 2016-06-09 |
US20120115187A1 (en) | 2012-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2430164A4 (en) | Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein | |
IL215348A0 (en) | Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof | |
IL216619A0 (en) | Recombinant production of peptides | |
EP2547771A4 (en) | Production of proteins and polypeptides | |
EP2250278A4 (en) | Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications | |
IL230918A0 (en) | Modified proteins and peptides | |
PL2552242T3 (en) | Low protein infant formula with increased essential amino acids | |
HK1200489A1 (en) | Recombinant human naglu protein and uses thereof naglu | |
EP2593469A4 (en) | Modified polypeptides and proteins and uses thereof | |
EP2494053A4 (en) | Methods for the production of recombinant proteins with improved secretion efficiencies | |
IL187191A0 (en) | Incorporation of non-naturally encoded amino acids into proteins | |
EP2651964A4 (en) | Croos-linked peptides and proteins, methods of making same, and uses thereof | |
EP2350286A4 (en) | Recombinant nell protein production | |
IL232645A0 (en) | Recombinant proteins and their therapeutic uses | |
IL216543A (en) | Methods for improving the production of a recombinant human wild-type acid-beta-glucosidase protein | |
PL1998790T3 (en) | Compositions containing peptides with non-natural amino acids and methods of use | |
EP2408926A4 (en) | Production of recombinant proteins in ciliates and uses thereof | |
EP2968469A4 (en) | Peptides comprising non-natural amino acids and methods of making and using the same | |
EP2406276A4 (en) | Methods of renaturation of recombinant proteins | |
EP2456910A4 (en) | Differentiation of isobaric amino acids and other species | |
EP2154251A4 (en) | Expression system of recombinant proteins with enhanced yield and immunogenicity | |
EP2167665A4 (en) | A method of enhancing recombinant protein production | |
EP2244725A4 (en) | Novel peptides and protein and uses thereof | |
IL219182A0 (en) | 2-amino-3-methyl-hex-5-enoic acid and its use in the production of peptides such as bacitracins | |
GB0903746D0 (en) | Novel conjugated proteins and peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20111212 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20121004 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 15/65 20060101AFI20120927BHEP Ipc: C12P 21/04 20060101ALI20120927BHEP |
|
17Q | First examination report despatched |
Effective date: 20140401 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20161025 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAL | Information related to payment of fee for publishing/printing deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR3 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTC | Intention to grant announced (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20170330 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 910437 Country of ref document: AT Kind code of ref document: T Effective date: 20170815 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602010043751 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2640947 Country of ref document: ES Kind code of ref document: T3 Effective date: 20171107 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: PFENEX, INC. |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 910437 Country of ref document: AT Kind code of ref document: T Effective date: 20170719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171019 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171020 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171119 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171019 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602010043751 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 |
|
26N | No opposition filed |
Effective date: 20180420 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20100510 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170719 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170719 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20230310 Year of fee payment: 14 Ref country code: FR Payment date: 20230309 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230316 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20230314 Year of fee payment: 14 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230527 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230412 Year of fee payment: 14 Ref country code: ES Payment date: 20230601 Year of fee payment: 14 Ref country code: DE Payment date: 20230314 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20230418 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20240104 AND 20240110 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602010043751 Country of ref document: DE Owner name: PELICAN TECHNOLOGY HOLDINGS, INC. (N.D. GES. D, US Free format text: FORMER OWNER: PFENEX, INC., SAN DIEGO, CALIF., US |